Improving inter-observer agreement and certainty level in diagnosing and grading papillary urothelial neoplasms: Usefulness of a Bayesian belief network

European Urology

Volumn 41, Issue 4, 2002, Pages 449-457

  Montironi, Rodolfo ^a   Mazzucchelli, Roberta ^a   Colanzi, Paola ^a   Streccioni, Marco ^a   Scarpelli, Marina ^a   Thompson, Deborah ^b   Bartels, Peter H ^b  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

Bayesian belief network; Grading; Papillary carcinoma; Papilloma; Urinary bladder; Urothelial papillary lesions

Indexed keywords

ARTICLE; BAYES THEOREM; BLADDER; CANCER CLASSIFICATION; CANCER GRADING; CONTROLLED STUDY; DIAGNOSTIC ERROR; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MEDICAL DECISION MAKING; MEDICAL EDUCATION; MICROSCOPY; OBSERVER VARIATION; OUTCOMES RESEARCH; PAPILLARY CARCINOMA; PAPILLOMA; PRIORITY JOURNAL; UROGENITAL TRACT TUMOR; UROTHELIAL PAPILLOMA;

BAYES THEOREM; CARCINOMA, PAPILLARY; HUMANS; OBSERVER VARIATION; UROLOGIC NEOPLASMS;

EID: 0036555363     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0302-2838(02)00028-3     Document Type: Article

References (35)

1. Epstein JI, Amin MB, Reuter VR, Mostofi FK. The Bladder Consensus Conference Committee: The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Am J Surg Pathol 1998;22:1435-48.
2. Bostwick DG, Mikuz G, Algaba F, Bono A, Burke HB, et al. Histopathology of bladder cancer. Virchows Arch, in press.
3. Mostofi FK, Sobin LH, Torloni H. Histological typing of urinary bladder tumours. In: International Histological Classification of Tumours, no. 10. Geneva: WHO, 1973. pp. 29-31.
4. Jordan AM, Weingarten J, Murphy WM. Transitional cell neoplasms of the urinary bladder: Can biologic potential be predicted from histologic grading? Cancer 1987;60:2766-74.
5. Pauwels RPE, Schapers RFM, Smeets AW, Debruyne FM, Geraedts JP. Grading in superficial bladder cancer. Part I. Morphological criteria. Br J Urol 1988;61:129-34.
6. Carbin BE, Ekman P, Gustafson H, Christensen NJ, Sandstedt B, Silfversward C. Grading of human urothelial carcinoma based on nuclear atypia and mitotic frequency. Part I. Histological description. J Urol 1991;145:968-71.
7. Jakse G, Loidl W, Seeber G, Hofstadter F. Stage T1, grade 3 transitional cell carcinoma of the bladder: An unfavourable tumour. J Urol 1987;137:39-44.
8. Kakizoe T, Tobisu K, Mizunati T, Tsutsumi M, Tanaka Y, Sakamoto M. Analysis by step sectioning of early invasive bladder cancer with special reference to G3 pT1 disease. Jpn J Cancer Res 1992;83:1354-8.
9. Lipponen PK, Eskelinen MJ, Jauhiainen K, Harju E, Terho R, Haapasalo H. Prognostic factors in nodular transitional cell bladder tumours. Scand J Urol Nephrol 1993;27:205-10.
10. Lopez-Beltran A, Escudero AL, Carrasco-Aznar JC, Vicioso-Recio L. Human papillomavirus infection and transitional cell carcinoma of the bladder. Immunohistochemistry and in situ hybridisation. Pathol Res Pract 1996;192:154-9.
11. Murphy WM. ASCP survey on anatomic pathology examination of the urinary bladder. Am J Clin Pathol 1994;102:715-23.
12. Takashi M, Sakata T, Murase T, Hamajima N, Miyake K. Grade 3 bladder cancer with lamina propria invasion (pT1): Characteristics of tumour and clinical course. Nagoya J Med Sci 1991;53:1-8.
13. Kaubisch S, Lum BL, Reese J, Freiha F, Torti FM. Stage T1 bladder cancer: Grade is the primary determinant for risk of muscle invasion. J Urol 1991;146:28-31.
14. Thrasher JB, Frazier HA, Robertson JE, Dodge RK, Paulson DF. Clinical variables that serve as predictors of cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate. Cancer 1994;73:1708-15.
15. Jarkrans T, Vasko J, Bentgsson E, Choi HK, Malmström PU, Wester K, et al. Grading of transitional cell bladder carcinoma by image analysis of histological sections. Anal Cell Pathol 1995;8:135-58.
16. Kruger S, Muller H. Correlation of morphometry, nucleolar organiser regions, proliferating cell nuclear antigen and ki67 antigen expression with grading and staging in urinary bladder carcinomas. Br J Urol 1995;75:480-4.
17. Montironi R, Scarpelli M, Sisti S, Ansuini P, Pisani E, Mariuzzi GM. Quantitative analysis and malignancy progression of the papillary neoplasia of urinary bladder. Pathol Res Pract 1987;182:528-9.
18. Wojcik EM. Diagnostic and prognostic application of computer-based morphometry in bladder cancer. Urooncology 2000;1:43-50.
19. Bartels PH, Thompson D, Weber JE. Expert systems in histopathology. Part IV. The management of uncertainty. Anal Quant Cytol Histol 1992;14:1-13.
20. Montironi R, Bartels PH, Thomson D, Scarpelli M, Hamilton PW. Prostatic intraepithelial neoplasia: Development of Bayesian belief network for diagnosis and grading. Anal Quant Cytol Histol 1994;16:101-12.
21. Montironi R, Bartels PH, Thomson D, Scarpelli M, Hamilton PW. Prostatic intraepithelial neoplasia: Performance of a Bayesian belief network for diagnosis and grading. J Pathol 1995;177:153-62.
22. Mazzucchelli R, Santinelli A, Colanzi P, Streccioni M, Lopez-Beltran A, Scarpelli M, et al. Urothelial papillary lesions. Development of a Bayesian belief network for diagnosis and grading. Anticancer Res 2001;21:1157-62.
23. Eble JN, Young RH. Tumors of the urinary tract. In: Fletcher CDM, editor. Diagnostic Histopathology of Tumors, vol. 1. London: Churchill Livingstone, 2000. pp. 516-48.
24. Ayala AG, Ro JY. Pre-malignant lesions of the urothelium and transitional cell tumors. In: Young RH, editor. Pathology of the Urinary Bladder, Vol. 13. New York: Churchill Livingstone, 1989. p. 65-101.
25. Malmström PU, Bush C, Norlén BJ. Recurrence, progression and survival in bladder cancer. A retrospective analysis of 231 patients with 5-year follow-up. Scand J Urol Nephrol 1987;21:185-95.
26. Ooms ECM, Anderson WAD, Alons CL, Boon ME, Veldhuizen RW. Analysis of the performance of pathologists in the grading of bladder tumors. Hum Pathol 1983;14:140-3.
27. Langley FA, Baak JPA, Oort J. Diagnosis: Error sources. In: Baak JPA, editor. Manual of Quantitative Pathology in Cancer Diagnosis and Prognosis. Berlin: Springer, 1991. p. 19-27.
28. Montironi R, Bartels PH, Thomson D, Scarpelli M, Hamilton PW. Prostatic intraepithelial neoplasia: Performance of a Bayesian belief network for diagnosis and grading. J Pathol 1995;177:153-62.
29. Montironi R, Mazzucchelli R, Santinelli A, Hamilton PW, Thompson D, Bartels PH. Case diagnosis as positive identification in prostatic neoplasia. Anal Quant Cytol Histol 1998;20:424-36.
30. Bartels PH, Thompson D, Weber JE. Diagnostic and prognostic decision support systems. Pathologica 1995;87:221-36.
31. Hamilton PW, Anderson N, Bartels PH, Thompson D. Expert system support using Bayesian belief networks in the diagnosis of fine-needle aspiration biopsy specimens of the breast. J Clin Pathol 1994;47:329-36.
32. Hamilton PW, Montironi R, Abmayr W, Bibbo M, Anderson N, Thompson D, et al. Clinical applications of Bayesian belief networks in pathology. Pathologica 1995;87:237-45.
33. Montironi R, Bartels PH, Hamilton PW, Thompson D. Atypical adenomatous hyperplasia (adenosis) of the prostate: Development of a Bayesian belief networks for its distinction from well-differentiated adenocarcinoma. Hum Pathol 1996;27:396-407.
34. Morrison ML, McCluggage WG, Price G, Diamond J, Sheeran MRM, Mulholland KM, et al. Expert system support using a Bayesian belief network for the classification of endometrial hyperplasia. J Pathol, in press.
35. Eaden J, Abrams K, McKay H, Denley H, Mayberry J. Inter-observer variation between general and specialist gastrointestinal pathologists obtained a similar result when grading dysplasia in ulcerative colitis. J Pathol 2001;194:152-7.